The DNA damage response and cancer therapy
- PMID: 22258607
- DOI: 10.1038/nature10760
The DNA damage response and cancer therapy
Abstract
Genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of DNA damage, tumour-specific DNA repair defects, and a failure to stop or stall the cell cycle before the damaged DNA is passed on to daughter cells. Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities. A better understanding of the cellular response to DNA damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease.
Similar articles
-
PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells.PLoS One. 2016 Jul 18;11(7):e0159341. doi: 10.1371/journal.pone.0159341. eCollection 2016. PLoS One. 2016. PMID: 27428646 Free PMC article.
-
Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers.Expert Opin Ther Targets. 2019 Sep;23(9):773-785. doi: 10.1080/14728222.2019.1654458. Epub 2019 Aug 13. Expert Opin Ther Targets. 2019. PMID: 31394942 Review.
-
Strategies for targeting the DNA damage response for cancer therapeutics.Chin J Cancer. 2012 Aug;31(8):359-63. doi: 10.5732/cjc.012.10087. Epub 2012 Jun 14. Chin J Cancer. 2012. PMID: 22704491 Free PMC article. Review.
-
The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer.EMBO Rep. 2019 Mar;20(3):e46821. doi: 10.15252/embr.201846821. Epub 2019 Jan 21. EMBO Rep. 2019. PMID: 30665945 Free PMC article.
-
DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.Clin Ther. 2016 Jul;38(7):1577-88. doi: 10.1016/j.clinthera.2016.06.006. Epub 2016 Jun 29. Clin Ther. 2016. PMID: 27368114 Review.
Cited by
-
Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy.Nat Commun. 2024 May 30;15(1):4616. doi: 10.1038/s41467-024-48214-3. Nat Commun. 2024. PMID: 38816355 Free PMC article.
-
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.Breast Cancer Res Treat. 2024 May 30. doi: 10.1007/s10549-024-07362-2. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38814507
-
Narrative review on the role of immunotherapy in early triple negative breast cancer: unveiling opportunities and overcoming challenges.Transl Breast Cancer Res. 2023 Apr 30;4:16. doi: 10.21037/tbcr-23-17. eCollection 2023. Transl Breast Cancer Res. 2023. PMID: 38751461 Free PMC article. Review.
-
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities.Int J Mol Sci. 2024 Apr 24;25(9):4624. doi: 10.3390/ijms25094624. Int J Mol Sci. 2024. PMID: 38731844 Free PMC article. Review.
-
Comprehensive analysis of INTS family related to expression, prognosis, diagnosis and immune features in hepatocellular carcinoma.Heliyon. 2024 Apr 24;10(9):e30244. doi: 10.1016/j.heliyon.2024.e30244. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720706 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases